48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.

by Dipen A Patel, Sonya J Snedecor, Wing Yu Tang, Lavanya Sudharshan, Jessica W Lim, Robert Cuffe, Sonia Pulgar, Kim A Gilchrist, Rodrigo Refoios Camejo, Jennifer Stephens, Garrett Nichols
Published 2014-01-01